查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012035

生物種子處理市場：依微生物類型、應用方法、製劑形式、作物類型和銷售管道分類－2026-2032年全球市場預測

Biological Seed Treatment Market by Microbial Type, Application Method, Formulation, Crop Type, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物種子處理市場價值將達到 17.1 億美元，到 2026 年將成長到 19.4 億美元，到 2032 年將達到 45.9 億美元，年複合成長率為 15.17%。

主要市場統計數據
基準年 2025 17.1億美元
預計年份：2026年 19.4億美元
預測年份 2032 45.9億美元
複合年成長率 (%) 15.17%

生物種子處理簡述：說明影響生物種子處理技術應用和創新的技術交會點、生產者動機和營運重點。

生物種子處理領域融合了農業、微生物學和永續農業，為提高種子性能和促進作物早期生長提供了廣泛的解決方案，同時減少了對合成材料的依賴。微生物製劑、遞送技術和監管核准的創新正迅速吸引種子企業、農藥生產商和種植者的關注，他們都在尋求兼顧生產力和環境保護。

關鍵且相互整合的技術、監管和商業性變革正在重塑生物種子處理領域的創新路徑和競爭優勢。

在技​​術進步、監管改革和價值鏈重組的推動下，生物種子處理領域正經歷著一場決定性的變革。在研發方面，更快速的菌株發現工具、高通量篩檢以及製劑科學的進步，使得多種微生物得以商業化，並提高了其保存期限和種子附著力。同時，與數位農業和數據驅動決策支援的融合，正將生物製品與精準播種和變數施肥技術相結合，為種植者創造更具針對性的價值提案。

2025 年美國關稅政策將如何重塑整個生物種子加工價值鏈的供應鏈、籌資策略和跨國合作。

美國2025年實施的關稅政策調整對生物種子處理生態系統產生了複雜的影響，波及原料採購、成分流動和跨國合作。由於許多高效微生物菌株、載體材料和特殊添加劑都存在於複雜的國際供應鏈中，對某些進口原料徵收的關稅改變了成本結構，迫使生產商和配方商即時調整營運。

基於細分市場的洞察揭示了微生物種類、應用方法、配方、作物特異性和銷售管道如何決定產品和商業策略。

透過市場區隔所獲得的洞察，為產品開發人員和市場推廣團隊提供了清晰的技術和商業性路徑。微生物的類型至關重要。細菌菌株通常具有特定的促生長、抑病或營養活化功能，而真菌菌株則提供不同的作用機制，例如菌根共生和拮抗活性。了解這些作用機制、穩定性和適用性的差異，對於配方選擇和目標作物策略都大有裨益。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和業務重點可作為市場進入和業務擴大策略的指南。

區域趨勢塑造了生物種子處理領域的機會和實施重點。在美洲，成熟的農業供應鏈和大規模的行栽作物種植系統催生了對可擴展、舉措種子處理的需求，這些需求需與病蟲害綜合防治方案和零售商管理計劃相契合。同時，田間示範和與經銷商建立牢固的關係對於大規模商業農場的推廣應用仍然至關重要。

主要企業如何將藥物發現、製劑工程和商業性執行結合，從而在生物種子處理領域建立永續的競爭優勢？

該領域的主要企業正透過整合涵蓋微生物發現、製劑工程、種子處理適用性測試和銷售管道執行等多學科能力來建立其競爭優勢。技術提供者、種子企業和特種製劑生產商之間的策略合作夥伴關係，能夠將有前景的實驗室成果快速轉化為實際的農場應用，同時分擔研發和註冊過程中涉及的資金和監管負擔。

為高階主管提供可操作的、高優先級的行動方案，以加速採用生物種子處理技術，增強供應韌性，並協調監管和商業策略。

產業領導者應優先考慮能夠加速產品市場契合度、同時確保供應鏈韌性和合規性的整合策略。首先，應投資於能夠解決種子品系相容性、儲存穩定性和易用性問題的配方平台，從而減輕種子加工商和經銷商的負擔。同時，應投入資源進行強力的田間檢驗項目，以在具有代表性的地區和種植系統中產生可重複的農業化學品證據。

概述透明的調查方法，描述資料來源、相關人員參與和分析技術，以產生對生物種子處理的實用見解。

本研究整合了一手和二手資料，建構了產品、監管、區域和競爭趨勢的全面圖像。一手資料包括對研發經理、種子技術專家、監管專家和銷售管道夥伴的結構化訪談，並輔以田間農業回饋，以實際結果佐證技術主張。二手資料涵蓋同行評審文獻、監管指導文件、行業協會公告和公開的企業資訊披露，從而對趨勢進行多角度分析並檢驗相關主張。

一個全面的結論強調科學機會、商業性紀律和供應鏈韌性，以此作為擴大生物種子處理的藍圖。

生物種子處理領域日新月異，既蘊含豐富的科學機遇，也面臨複雜的商業性挑戰。微生物技術的發現和配方科學的進步為產品性能的提升鋪平了道路，但不斷變化的法規、供應鏈以及生產商的期望，正迫使我們重新定義產品的研發和交付方式。在這種環境下取得成功，需要一種平衡的策略，將卓越的技術、嚴謹的營運和敏銳的市場洞察力融為一體。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按微生物類型分類的生物種子處理市場

  • 細菌
  • 真菌

第9章：生物種子處理的市場應用方法

  • 種子披衣
    • 覆蓋
    • 薄膜塗層
  • 種子拌藥
  • 種子製粒

第10章：依配方分類的生物種子處理市場

  • 顆粒
  • 液體
    • 油膩的
    • 水溶液
  • 粉末

第11章：生物種子處理市場：依作物類型分類

  • 糧食
    • 玉米
    • 米
    • 小麥
  • 水果和蔬菜
  • 油籽/豆類
    • 油菜籽
    • 大豆
    • 向日葵

第12章：生物種子加工市場：依銷售管道分類

  • 離線
  • 線上

第13章：生物種子處理市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：生物種子處理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：生物種子處理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國生物種子處理市場

第17章：中國生物種子加工市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agrinos AS
  • AMVAC Chemical Corporation
  • BASF SE
  • Bayer AG
  • Bioworks Inc
  • Certis USA LLC
  • Corteva Agriscience
  • East-West Seed
  • FMC Corporation
  • Germains Seed Technology
  • Groupe Limagrain SA
  • Incotec Group BV
  • Italpollina SpA
  • Koppert Biological Systems
  • Marrone Bio Innovations Inc
  • Novozymes A/S
  • Nufarm Limited
  • Plant Health Care plc
  • Rizobacter Argentina SA
  • SAKATA SEED CORPORATION
  • Sumitomo Chemical Co Ltd
  • Syngenta AG
  • UPL Limited
  • Valent BioSciences LLC
  • Verdesian Life Sciences LLC
Product Code: MRR-43539E5D2D2B

The Biological Seed Treatment Market was valued at USD 1.71 billion in 2025 and is projected to grow to USD 1.94 billion in 2026, with a CAGR of 15.17%, reaching USD 4.59 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.71 billion
Estimated Year [2026] USD 1.94 billion
Forecast Year [2032] USD 4.59 billion
CAGR (%) 15.17%

A concise orientation to biological seed treatments explaining technological intersections, grower drivers, and operational priorities shaping adoption and innovation

The biological seed treatment sector sits at the intersection of agronomy, microbiology, and sustainable agriculture, offering a range of solutions that enhance seed performance and early crop vigor while reducing reliance on synthetic inputs. Innovations in microbial formulations, delivery technologies, and regulatory acceptance have accelerated interest from seed companies, agrochemical firms, and growers aiming to balance productivity with environmental stewardship.

This introduction frames the strategic importance of biological seed treatments by outlining core drivers and operational realities shaping adoption. It highlights how increasing emphasis on soil health, integrated pest management, and stewardship programs is elevating the role of seed-applied biologicals as part of broader crop protection and nutrition packages. The narrative further explains how evolving production practices and farm-level decision criteria are redefining product development priorities, creating new technical demands around compatibility with seed treatments, storage stability, and application efficacy.

Finally, this section establishes the analytical approach used throughout the document by connecting technological trends, regulatory influences, and commercial dynamics to practical implications for stakeholders. It sets the stage for subsequent sections that examine landscape shifts, policy impacts, segmentation nuances, regional dynamics, competitive positioning, and actionable recommendations for leaders seeking to translate scientific promise into commercial success.

Critical and converging technological, regulatory, and commercial shifts that are reshaping innovation pathways and competitive advantage in biological seed treatments

The landscape for biological seed treatments is undergoing decisive shifts driven by technological advances, regulatory recalibrations, and reconfigured value chains. Across research and development, accelerated strain discovery tools, high-throughput screening, and improved formulation science are enabling diverse microorganisms to be productized with enhanced shelf life and seed adherence. At the same time, integration with digital agronomy and data-driven decision support is aligning biological offerings with precision sowing and variable-rate practices, creating a more targeted value proposition for growers.

Regulatory frameworks are increasingly recognizing the distinct risk profiles of biologicals relative to synthetic chemistries, prompting more nuanced registration pathways and localized approval processes. This trend supports market entry for novel strains but also raises the bar for standardized testing, product characterization, and post-launch stewardship. Alongside these governance changes, commercial models are evolving; partnerships between seed companies, formulation specialists, and distributors are becoming more collaborative, reflecting the need to bundle biologicals with other seed technologies and services.

Furthermore, supply chain resilience and sourcing strategies are being revisited as manufacturers prioritize localized production and redundancy to mitigate logistics disruptions. Consumer expectations and retailer sustainability commitments are also pressuring the industry to demonstrate measurable environmental outcomes, reinforcing the need for robust field validation and transparent communication. Collectively, these transformative shifts are recalibrating competitive advantage toward players who can combine scientific credibility, commercialization agility, and demonstrable on-farm benefits.

How 2025 United States tariff policies are reshaping supply chains, sourcing strategies, and cross-border collaboration across the biological seed treatment value chain

Policy changes enacted in 2025 regarding tariffs in the United States have introduced complex ramifications for the biological seed treatment ecosystem, affecting raw material sourcing, component movement, and cross-border collaborations. Because many active microbial strains, carrier materials, and specialized excipients are part of intricate international supply chains, duties applied to certain imported inputs have altered cost structures and prompted immediate operational adjustments among manufacturers and formulators.

This tariff environment has incentivized relocation of certain production steps closer to end markets, with firms reassessing the distribution of fermentation, formulation, and packaging activities. As a consequence, procurement teams are placing greater emphasis on supplier qualification and domestic alternative sourcing to reduce exposure to trade-related price volatility. These shifts are also prompting contract renegotiations and longer-term supplier agreements designed to secure throughput and maintain product continuity for seed companies and their channel partners.

In addition, the tariffs have had indirect effects on collaborative R&D and knowledge exchange. Cross-border academic-industry projects and contract research organizations face higher transactional friction when materials and prototypes move across borders, encouraging stakeholders to increase local capacity for early-stage development and testing. Meanwhile, distributors and seed companies are adapting commercialization timelines and inventory strategies to ensure availability at sowing windows, prioritizing supplier diversity and logistical redundancy. Therefore, the cumulative impact of the 2025 tariff measures is accelerating structural reconfiguration across the value chain, compelling industry participants to invest in localized capabilities, strategic sourcing, and risk mitigation to preserve market continuity and meet grower needs.

Segmentation-driven insights revealing how microbial type, application method, formulation, crop specificity, and sales channels determine product and commercial strategy

Insights derived from segmentation reveal distinct technical and commercial pathways that product developers and go-to-market teams must navigate. Microbial type matters: bacterial strains often deliver specific growth-promoting, disease-suppressive, or nutrient-mobilizing functions, while fungal strains provide alternative modes of action including mycorrhizal associations and antagonist behavior. Recognizing differences in mode of action, stability, and compatibility informs both formulation choices and target-crop strategies.

Application method differentiates both product design and field performance. Seed coating approaches prioritize uniform coverage and adhesion, with encrusting enabling high-load applications and film coating delivering thin, uniform layers that facilitate mechanical seed handling. Seed dressing provides a balance between ease of application and protective benefits during storage and sowing, whereas seed pelleting modifies seed geometry for small-seeded crops or precision sowing systems. Each method imposes constraints on formulation viscosity, particle size, and carrier selection, shaping development priorities.

Formulation format drives shelf life, distribution logistics, and end-user handling. Granular formats can offer physical robustness for certain deployment systems, liquids afford ease of mixing and rapid seed surface interaction with oil-based variants enhancing adherence and water-based variants improving dispersibility, while powders remain attractive where drying stability and lightweight transport are important. The choice among granule, liquid, and powder at development stage directly affects production investments and compatibility with seed treatment lines.

Crop type determines commercial focus and performance targets. Cereals such as corn, rice, and wheat present high-volume platforms where seed treatments must be compatible with established seed production and agronomic practices. Fruits and vegetables demand formulations that accentuate early vigor and transplant success, whereas oilseeds and pulses including rapeseed, soybean, and sunflower require solutions tailored to seed size, handling, and disease pressures. Sales channel considerations also influence go-to-market strategy: offline channels remain dominant for relationship-driven sales, while online channels are emerging as efficient means to reach specialty growers and remote markets. Synthesizing these segmentation dimensions provides a nuanced map for prioritizing product pipelines, tailoring registrational strategies, and designing commercial models that reflect crop- and channel-specific requirements.

Regional dynamics and operational priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform market entry and scaling strategies

Regional dynamics shape opportunity contours and executional priorities across the biological seed treatment landscape. In the Americas, established agricultural supply chains and large-scale row-crop systems create demand for scalable, mechanization-compatible seed treatments that align with integrated pest management programs and retailer stewardship initiatives. Meanwhile, field validation and strong distributor relationships remain pivotal for adoption in large commercial operations.

Europe, Middle East & Africa present a heterogeneous mix of regulatory environments and cropping systems that favor localized product adaptation and robust environmental safety data. In many parts of this region, policy drivers and retailer sustainability commitments accelerate interest in low-residue and biologically based inputs, making regulatory navigation and evidence of ecological benefit essential prerequisites for commercial success.

Asia-Pacific is characterized by diverse farm sizes, crop mixes, and rapidly evolving input retail models, with smallholder prevalence in some markets and high-intensity commercial agriculture in others. This heterogeneity necessitates differentiated packaging, dosing, and application methods, as well as flexible distribution strategies that can address both institutional buyers and fragmented retail networks. Across all regions, regional infrastructure, local manufacturing capacity, and regulatory clarity remain decisive factors informing where companies elect to invest in production and field demonstration activities.

How leading firms are combining discovery, formulation engineering, and commercial execution to establish durable competitive advantages in biological seed treatments

Leading companies in the space are building advantage by integrating multidisciplinary capabilities that span microbial discovery, formulation engineering, seed treatment compatibility testing, and channel execution. Strategic collaborations between technology providers, seed companies, and specialty formulators are enabling faster translation from lab-scale promise to on-farm performance, while also sharing the capital and regulatory burden associated with development and registration.

Competitive differentiation is being achieved through deep investments in proprietary strain libraries, formulation platforms that enhance survivability and adherence on seed surfaces, and tailored service offerings such as agronomic support and stewardship programs. Firms that combine technical credibility with robust field-validation protocols are better positioned to secure distribution agreements and channel trust. Additionally, upstream investments in manufacturing flexibility and redundant supply capabilities help companies mitigate trade-related risks and maintain supply continuity during peak sowing windows.

Finally, customer-centric approaches that incorporate grower trials, localized technical support, and clear messaging around compatibility with existing seed treatment chemistries are proving essential for adoption. Companies that demonstrate measurable agronomic benefit and operational ease of use will likely sustain stronger relationships with seed processors, distributors, and end-users.

Practical and prioritized actions for executives to accelerate adoption, strengthen supply resilience, and align regulatory and commercial strategies for biological seed treatments

Industry leaders should prioritize an integrated strategy that accelerates product-market fit while safeguarding supply chain resilience and regulatory compliance. First, invest in formulation platforms that address seed-line compatibility, storage stability, and application ergonomics to reduce friction for seed processors and distributors. Concurrently, allocate resources to robust field validation programs that generate reproducible agronomic evidence across representative geographies and cropping systems.

Second, diversify sourcing and manufacturing footprints to mitigate trade-related disruptions and provide faster response to regional demand shifts. This includes developing localized fermentation and formulation capabilities where feasible, as well as qualifying multiple suppliers for critical excipients and carriers. Third, pursue strategic partnerships that blend proprietary microbial assets with established seed treatment infrastructure, enabling faster scale-up and shared commercial risk.

Fourth, align commercial models with channel needs by offering tailored packaging, dose formats, and technical services that support both offline distributor networks and emerging online procurement channels. Fifth, engage proactively with regulatory authorities and participate in harmonization efforts to shape practical, science-based registration pathways. Lastly, strengthen value communication through transparent performance data, environmental benefit narratives, and clear stewardship guidelines to build trust across growers, retailers, and policymakers.

A transparent methodological overview describing data sources, stakeholder engagements, and analytical approaches employed to produce actionable biological seed treatment insights

This research synthesized primary and secondary intelligence to develop a comprehensive view of product, regulatory, regional, and competitive dynamics. Primary inputs included structured interviews with R&D leaders, seed technologists, regulatory specialists, and channel partners, supplemented by field-level agronomic feedback to ground technical claims in practical outcomes. Secondary inputs encompassed peer-reviewed literature, regulatory guidance documents, trade association communications, and publicly available company disclosures to triangulate trends and validate assertions.

Analytical methods combined qualitative thematic analysis with comparative evaluation of formulation platforms and application methods. Segmentation mapping was employed to connect microbial characteristics with formulation choices, application constraints, and crop-specific needs. Regional analysis integrated policy review, supply chain assessment, and go-to-market considerations to highlight differential requirements across geographies. Attention was given to ensuring that conclusions reflect operational realities and stakeholder perspectives rather than relying solely on theoretical performance metrics.

Where possible, findings were cross-checked with multiple independent sources and iterated through follow-up discussions to refine interpretations. Limitations were acknowledged, including variability in on-farm performance due to environmental heterogeneity and differences in seed production practices. These methodological choices were selected to deliver actionable intelligence that balances scientific rigor with commercial relevance.

An integrated conclusion emphasizing scientific opportunity, commercial discipline, and supply chain resilience as the blueprint for scaling biological seed treatments

The evolving biological seed treatment landscape presents a compelling combination of scientific opportunity and commercial complexity. Advances in microbial discovery and formulation science are unlocking new performance pathways, while shifts in regulation, supply chains, and grower expectations are redefining how products must be developed and delivered. Success in this environment requires a balanced approach that pairs technical excellence with operational discipline and market-savvy execution.

Stakeholders who excel will be those that can translate microbial potential into robust, user-friendly products supported by rigorous field evidence and resilient supply chains. They will also engage proactively with regulators and channel partners to streamline adoption and build confidence among end-users. In short, the path to sustainable, scaled impact lies in integrating discovery, formulation, validation, and commercialization into a cohesive strategy that anticipates regional nuances and adapts to policy shifts.

This conclusion underscores a pragmatic mandate for the industry: continue investing in science, but do so in tandem with pragmatic supply chain planning and clear commercial propositions that address the everyday priorities of seed processors, distributors, and growers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Seed Treatment Market, by Microbial Type

  • 8.1. Bacteria
  • 8.2. Fungi

9. Biological Seed Treatment Market, by Application Method

  • 9.1. Seed Coating
    • 9.1.1. Encrusting
    • 9.1.2. Film Coating
  • 9.2. Seed Dressing
  • 9.3. Seed Pelleting

10. Biological Seed Treatment Market, by Formulation

  • 10.1. Granule
  • 10.2. Liquid
    • 10.2.1. Oil Based
    • 10.2.2. Water Based
  • 10.3. Powder

11. Biological Seed Treatment Market, by Crop Type

  • 11.1. Cereals
    • 11.1.1. Corn
    • 11.1.2. Rice
    • 11.1.3. Wheat
  • 11.2. Fruits & Vegetables
  • 11.3. Oilseeds & Pulses
    • 11.3.1. Rapeseed
    • 11.3.2. Soybean
    • 11.3.3. Sunflower

12. Biological Seed Treatment Market, by Sales Channel

  • 12.1. Offline
  • 12.2. Online

13. Biological Seed Treatment Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biological Seed Treatment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biological Seed Treatment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Biological Seed Treatment Market

17. China Biological Seed Treatment Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agrinos AS
  • 18.6. AMVAC Chemical Corporation
  • 18.7. BASF SE
  • 18.8. Bayer AG
  • 18.9. Bioworks Inc
  • 18.10. Certis USA LLC
  • 18.11. Corteva Agriscience
  • 18.12. East-West Seed
  • 18.13. FMC Corporation
  • 18.14. Germains Seed Technology
  • 18.15. Groupe Limagrain SA
  • 18.16. Incotec Group BV
  • 18.17. Italpollina SpA
  • 18.18. Koppert Biological Systems
  • 18.19. Marrone Bio Innovations Inc
  • 18.20. Novozymes A/S
  • 18.21. Nufarm Limited
  • 18.22. Plant Health Care plc
  • 18.23. Rizobacter Argentina S.A.
  • 18.24. SAKATA SEED CORPORATION
  • 18.25. Sumitomo Chemical Co Ltd
  • 18.26. Syngenta AG
  • 18.27. UPL Limited
  • 18.28. Valent BioSciences LLC
  • 18.29. Verdesian Life Sciences LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL SEED TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ENCRUSTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ENCRUSTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ENCRUSTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FILM COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FILM COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FILM COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED DRESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED DRESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED DRESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED PELLETING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED PELLETING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED PELLETING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OIL BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OIL BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OIL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WATER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WATER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WATER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WHEAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WHEAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WHEAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RAPESEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RAPESEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RAPESEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUNFLOWER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUNFLOWER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUNFLOWER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 208. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 216. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 218. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)